Ennature Bio Pharma Limited - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Ennature Bio Pharma Limited · Financial Result · 12 Nov 2026, 7:10 pm
Ennature Bio Pharma Limited - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 7,846 (+44.9% YoY | -13.2% QoQ) ■ EBITDA: 1,034 (+71.2% YoY | +3.5% QoQ) ■ EBITDA Margin (%): 13.2 (+202 bps YoY | +213 bps QoQ) ■ PAT: 489 (Loss to Profit YoY | +4.9% QoQ) ■ EPS (INR): 2.19 (Loss to Profit YoY | +4.8% QoQ)
Original exchange filing (PDF)
More announcements from Ennature Bio Pharma Limited
- Please find attached. · 12 Nov 2026
- Please find attached. · 12 Nov 2026
- Ennature Bio Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Please find attached. · 12 Nov 2026
- ENNATURE BIO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 12 Nov 2026
- ENNATURE BIO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 12 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 12 Nov 2026
- Ennature Bio Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Please refer attachment · 12 Nov 2026
